跳至主要内容
临床试验/TCTR20190724005
TCTR20190724005招募中未知

Comparison of efficacy and safety of pioglitazone versus metformin for moderate-to-severe chronic plaque psoriasis in patients with prediabetes or newly-diagnosed diabetes who have never taken anti-diabetic agents: a parallel, randomized, open-label,

Dermatological Society of Thailand (pending)0 个研究点目标入组 40 人开始时间: 2019年7月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • -Minimum 18 Years
  • -Extensive chronic plaque-type psoriasis (at least 5% body surface area involvement)
  • -Prediabetes (fasting blood glucose 100-125 mg/dL or HbA1C 5.7-6.4%) or diabetes mellitus (fasting blood glucose > 126 mg/dL or HbA1C > 6.5)

排除标准

  • -Pregnancy or lactation
  • -History of pioglitazone or metformin allergy
  • -Congestive heart failure (NYHA class III or IV) or ischemic heart disease
  • -History of diabetic ketoacidosis
  • -Impaired hepatic function (>2.5 times upper range limit)
  • -Impaired renal function (estimated glomerular filtration rate < 30 mL/min per 1.73 m²)
  • -Obesity (body mass index > 30 kg/m2)
  • -Alcoholism
  • -History of bladder cancer
  • -History of bony fracture

研究者

发起方
Dermatological Society of Thailand (pending)

相似试验